TSC2 and lymphangioleiomyomatosis: Interestingly, the expression of VEGFD, a validated LAM biomarker71, was much lower than MDK (a potent angiogenic and lymphangiogenic growth factor55,72) in LAM cells (Fig. 2o), suggesting a potential role of MDK in LAM-associated lymphangiogenesis.